Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 14.5 Cr.
- Current Price ₹ 4.52
- High / Low ₹ 29.0 / 3.78
- Stock P/E 1.97
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE 24.5 %
- ROE 29.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.29 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -14.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|
0.34 | 0.53 | 0.45 | 9.45 | 39.81 | 38.79 | |
0.57 | 0.61 | 0.53 | 8.93 | 31.54 | 31.43 | |
Operating Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 | 7.36 |
OPM % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% | 18.97% |
0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | 7.36 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
-0.26 | -0.10 | -0.12 | 0.52 | 8.27 | 7.35 | |
EPS in Rs | 0.16 | 2.58 | 2.30 | |||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 321% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 1490% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 25% |
3 Years: | 21% |
1 Year: | -75% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 |
Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 |
3.42 | 3.42 | 3.42 | 10.91 | 0.02 | |
0.23 | 0.25 | 0.27 | 0.02 | 0.02 | |
Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 |
0.52 | 0.49 | 0.45 | 0.00 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 |
3.97 | 4.57 | 4.51 | 16.89 | 50.61 | |
Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
-13.46 | -25.48 | ||||
0.00 | -0.01 | ||||
12.58 | 25.46 | ||||
Net Cash Flow | -0.88 | -0.03 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Debtor Days | 2,286.62 | 1,246.51 | 1,476.22 | 132.87 | 107.09 |
Inventory Days | 16.95 | 50.98 | |||
Days Payable | 0.00 | 0.00 | |||
Cash Conversion Cycle | 2,286.62 | 1,246.51 | 1,476.22 | 149.81 | 158.07 |
Working Capital Days | 4,004.26 | 2,975.09 | 3,422.89 | 152.18 | 177.41 |
ROCE % | -1.40% | -1.71% | 24.51% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
18 Aug - Newspaper Publication for Unaudited Standalone and Consolidated Financial Result for the quarter ended 30th June, 2025
-
Unaudited Standalone And Consolidated Financial Result For The Quarter Ended June 30, 2025
14 Aug - Q1 FY2025 unaudited results: net loss Rs 7.06 lakh; limited review completed; no exceptional items.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th August, 2025
14 Aug - Q1 FY2025 unaudited financial results showing loss approved and limited review completed.
-
Board Meeting Intimation for Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On June 30, 2025
7 Aug - Board meeting on 14 Aug 2025 to approve Q1 June 2025 unaudited financial results.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 28 Jul
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector